Ibrutinib as a potential therapeutic for cocaine use disorder.

Huggett, Spencer B; Hatfield, Jeffrey S; Walters, Joshua D; McGeary, John E; Welsh, Justine W; Mackay, Trudy F C; Anholt, Robert R H; Palmer, Rohan H C

Huggett, Spencer B; Hatfield, Jeffrey S; Walters, Joshua D; McGeary, John E; Welsh, Justine W; Mackay, Trudy F C; Anholt, Robert R H; Palmer, Rohan H C.

Affiliation

Huggett SB; Behavioral Genetics of Addiction Laboratory, Department of Psychology at Emory University, Atlanta, GA, USA. Spencer.B.Huggett@emory.edu.
Hatfield JS; Department of Genetics and Biochemistry and Center for Human Genetics, Clemson University, Greenwood, SC, USA.
Walters JD; Department of Genetics and Biochemistry and Center for Human Genetics, Clemson University, Greenwood, SC, USA.
McGeary JE; Department of Psychiatry and Human Behavior, Brown University, Providence, RI, USA.
Welsh JW; Providence Veterans Affairs Medical Center, Providence, RI, USA.
Mackay TFC; Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, GA, USA.
Anholt RRH; Department of Genetics and Biochemistry and Center for Human Genetics, Clemson University, Greenwood, SC, USA.
Palmer RHC; Department of Genetics and Biochemistry and Center for Human Genetics, Clemson University, Greenwood, SC, USA.

Transl Psychiatry ; 11(1): 623, 2021 12 08.

Article in En | MEDLINE | ID: mdl-34880215

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cocaine / Substance-Related Disorders / Cocaine-Related Disorders Limits: Animals Language: En Journal: Transl Psychiatry Year: 2021 Document type: Article Affiliation country: Estados Unidos

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google